Medical Physics

Medical Physics is the application of physics principles in medical diagnosis and treatment. Research activities range from basic scientific research to translational (bench-to-treatment couch) research.
All Medical Physicists in the Division have clinical, academic/teaching and research responsibilities. Along with an excellent complement of graduate students and technical personnel, members of the Division of Medical Physics are committed to providing leadership in the application of physics and engineering principles to cancer care.
Some research highlights for the Medical Physics Division:
  • Produced the world's first MR image during linear accelerator irradiation using a linear accelerator-Magnetic Resonance (linac-MR) hybrid system in December 2008.
    The Division's original work integrating a linear accelerator (linac) with a magnetic resonance imaging (MRI) system features:
    • 0.5 T MRI
    • 6 MV linac
    • 60 cm field
    See the Linac MR Project for more details.
  • The Image-Guided Adaptive Radiotherapy (IGAR) research program is unique and makes the Cross Cancer Institute a world leader in cancer molecular imaging and adaptive radiation therapy. Equipment includes:
  • Small bore 9.4T MR Imaging and Spectroscopy System
  • Very-high field (3T) whole body MR Imaging and Spectroscopy System
  • First Helical TomoTherapy™ unit in Canada was installed at the Cross Cancer Institute (CCI). The first patient was imaged on the TomoTherapy unit in June 2004, and the first protocol patients started treatment in July 2004.
  • Research has begun involving the recently opened Biomedical Beam Line of the Canadian Light Source in Saskatoon.
  • First Canadian cancer centre to accrue patients to the Radiation Therapy Oncology Group (RTOG) prostate, lung and bioblastoma 3D Conformal Radiation Therapy (3D-CRT) clinical trials.
  • The Cross Cancer Institute became an international leader in Intensity Modulated Radiation Therapy (IMRT) in 2000. The first patient in Canada using IMRT with inverse treatment planning began treatment at the CCI in April that year.
Research partners include:
  • National Research Council Canada - Institute for Biodiagnostics (NRC-IBD)
  • Radiation Therapy Oncology Group (RTOG)
Research and development in the Division of Medical Physics is currently supported through core funding, research grants, and industrial collaboration.
For further information, visit the Medical Physics website